Drag a card by its title · ⚙ to size, swap or remove

The company

Relmada Therapeutics, Inc.

RLMD · Nasdaq

Health CareBiotechnologyNot moving yet

RLMD stood above a rising 150-day average in 38 of the last 52 weekly readings, and has been out of that trend for the last 14 weeks. It is 44.9% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 14
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $5.7M
Insider sales, 12 months: $0
Officials’ trades on record: 2
Institutions holding: 123 (+22)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 38 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 2, Senate 0, executive 0; 1 people.

Who	Did	Amount	Traded
Chris Jacobs House: U.S. House ClerkNY27	sold	$1k–$15k	12 Dec 2022filed 20 Jan 2023
Chris Jacobs House: U.S. House ClerkNY27	bought	$1k–$15k	8 Nov 2022filed 12 Dec 2022

Insiders

Buy orders, 12 months10

Sale orders, 12 months0

Buyers · sellers4 · 0

Who	Did	Shares	Traded
Sergio TraversaChief Executive Officer	bought	100,000at $4.10	10 Sep 2026filed 11 Sep 2026
Maged ShenoudaChief Financial Officer	bought	79,800at $4.25	10 Sep 2026filed 11 Sep 2026
Sergio TraversaChief Executive Officer	bought	100,000at $4.18	9 Sep 2026filed 11 Sep 2026
Maged ShenoudaChief Financial Officer	bought	120,200at $4.20	9 Sep 2026filed 11 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders123+22 on the quarter

New · exited45 · 23

Reported value$694.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Jupiter Topco LLCnew · filed 14 Aug 2026	11,164,803$77.3M	+11,164,803
BlackRock, Inc.added · filed 7 Aug 2026	7,426,780$51.4M	+6,137,230+475.9%
Squadron Capital Management LLCreduced · filed 14 Aug 2026	7,350,000$50.9M	-1,124,571−13.3%
Venrock Adviser, LLCadded · filed 14 Aug 2026	6,844,305$47.4M	+2,000,925+41.3%
Spruce Street Capital LPadded · filed 13 Aug 2026	6,391,328$44.2M	+129,214+2.1%
ADAGE CAPITAL PARTNERS GP, L.L.C.unchanged · filed 14 Aug 2026	4,763,158$33.0M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,460,210$30.9M	+1,383,640+45.0%
Jones Hill Capital LPadded · filed 13 Aug 2026	3,655,075$25.3M	+3,312,323+966.4%
ORBIMED ADVISORS LLCreduced · filed 14 Aug 2026	3,631,195$25.1M	-1,084,669−23.0%
STATE STREET CORPadded · filed 7 Aug 2026	2,517,550$17.4M	+2,160,510+605.1%